APO Research
Talk to an analyst

APO RESEARCH · REPORT

Drug-Loadable Embolic Microspheres

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Drug-Loadable Embolic Microspheres Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

27 December 2025182 pages

Choose your research edition.

Industry ResearchDrug-Loadable Embolic Microspheres Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Drug-Loadable Embolic Microspheres Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Drug-Loadable Embolic Microspheres Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Drug-Loadable Embolic Microspheres Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Drug-Loadable Embolic Microspheres Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Drug-Loadable Embolic Microspheres market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Drug-Loadable Embolic Microspheres is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Drug-Loadable Embolic Microspheres is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Drug-Loadable Embolic Microspheres is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Drug-Loadable Embolic Microspheres is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Drug-Loadable Embolic Microspheres include Suzhou Hengrui Medical Equipment, Cardiolink Science, Varian, Terumo, Sirtex Medical, Merit Medical, Boston Scientific and ABK Biomedical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Drug-Loadable Embolic Microspheres market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Drug-Loadable Embolic Microspheres and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Drug-Loadable Embolic Microspheres sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Drug-Loadable Embolic Microspheres market size, projected growth trends, production technologies, key applications, and end-use industries.

Drug-Loadable Embolic Microspheres Segment by Company

Suzhou Hengrui Medical Equipment

Cardiolink Science

Varian

Terumo

Sirtex Medical

Merit Medical

Boston Scientific

ABK Biomedical

Drug-Loadable Embolic Microspheres Segment by Type

Radioactive Microspheres

Drug-eluting Microspheres

Drug-Loadable Embolic Microspheres Segment by Application

Primary Liver Cancer

Colorectal Cancer Liver Metastasis

Others

Drug-Loadable Embolic Microspheres Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug-Loadable Embolic Microspheres market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Drug-Loadable Embolic Microspheres and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug-Loadable Embolic Microspheres.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Drug-Loadable Embolic Microspheres market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Drug-Loadable Embolic Microspheres manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Drug-Loadable Embolic Microspheres in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Drug-Loadable Embolic Microspheres in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Drug-Loadable Embolic Microspheres Industry Trends Table 2. Drug-Loadable Embolic Microspheres Industry Drivers Table 3. Drug-Loadable Embolic Microspheres Industry Opportunities and Challenges Table 4. Drug-Loadable Embolic Microspheres Industry Restraints Table 5. Global Drug-Loadable Embolic Microspheres Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Drug-Loadable Embolic Microspheres Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Drug-Loadable Embolic Microspheres Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Drug-Loadable Embolic Microspheres Sales Market Share by Manufacturers Table 9. Global Drug-Loadable Embolic Microspheres Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Drug-Loadable Embolic Microspheres Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Drug-Loadable Embolic Microspheres Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Drug-Loadable Embolic Microspheres Manufacturers, Product Type & Application Table 13. Global Drug-Loadable Embolic Microspheres Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Drug-Loadable Embolic Microspheres by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Radioactive Microspheres Table 17. Major Manufacturers of Drug-eluting Microspheres Table 18. Global Drug-Loadable Embolic Microspheres Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Drug-Loadable Embolic Microspheres Sales by Type (2021-2026) & (K Units) Table 20. Global Drug-Loadable Embolic Microspheres Sales by Type (2027-2032) & (K Units) Table 21. Global Drug-Loadable Embolic Microspheres Sales Market Share by Type (2021-2026) Table 22. Global Drug-Loadable Embolic Microspheres Sales Market Share by Type (2027-2032) Table 23. Global Drug-Loadable Embolic Microspheres Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Drug-Loadable Embolic Microspheres Revenue by Type (2021-2026) & (K Units) Table 25. Global Drug-Loadable Embolic Microspheres Revenue by Type (2027-2032) & (K Units) Table 26. Global Drug-Loadable Embolic Microspheres Revenue Market Share by Type (2021-2026) Table 27. Global Drug-Loadable Embolic Microspheres Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Primary Liver Cancer Table 29. Major Manufacturers of Colorectal Cancer Liver Metastasis Table 30. Major Manufacturers of Others Table 31. Global Drug-Loadable Embolic Microspheres Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Drug-Loadable Embolic Microspheres Sales by Application (2021-2026) & (K Units) Table 33. Global Drug-Loadable Embolic Microspheres Sales by Application (2027-2032) & (K Units) Table 34. Global Drug-Loadable Embolic Microspheres Sales Market Share by Application (2021-2026) Table 35. Global Drug-Loadable Embolic Microspheres Sales Market Share by Application (2027-2032) Table 36. Global Drug-Loadable Embolic Microspheres Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Drug-Loadable Embolic Microspheres Revenue by Application (2021-2026) & (K Units) Table 38. Global Drug-Loadable Embolic Microspheres Revenue by Application (2027-2032) & (K Units) Table 39. Global Drug-Loadable Embolic Microspheres Revenue Market Share by Application (2021-2026) Table 40. Global Drug-Loadable Embolic Microspheres Revenue Market Share by Application (2027-2032) Table 41. Global Drug-Loadable Embolic Microspheres Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Drug-Loadable Embolic Microspheres Sales by Region (2021-2026) & (K Units) Table 43. Global Drug-Loadable Embolic Microspheres Sales Market Share by Region (2021-2026) Table 44. Global Drug-Loadable Embolic Microspheres Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Drug-Loadable Embolic Microspheres Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Drug-Loadable Embolic Microspheres Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Drug-Loadable Embolic Microspheres Sales by Country (2021-2026) & (K Units) Table 48. North America Drug-Loadable Embolic Microspheres Sales by Country (2027-2032) & (K Units) Table 49. Europe Drug-Loadable Embolic Microspheres Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Drug-Loadable Embolic Microspheres Sales by Country (2021-2026) & (K Units) Table 51. Europe Drug-Loadable Embolic Microspheres Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Drug-Loadable Embolic Microspheres Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Drug-Loadable Embolic Microspheres Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Drug-Loadable Embolic Microspheres Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Drug-Loadable Embolic Microspheres Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Drug-Loadable Embolic Microspheres Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Drug-Loadable Embolic Microspheres Sales by Country (2027-2032) & (K Units) Table 58. Global Drug-Loadable Embolic Microspheres Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Drug-Loadable Embolic Microspheres Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Drug-Loadable Embolic Microspheres Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Drug-Loadable Embolic Microspheres Revenue Market Share by Region (2021-2026) Table 62. Global Drug-Loadable Embolic Microspheres Revenue Market Share by Region (2027-2032) Table 63. Suzhou Hengrui Medical Equipment Company Information Table 64. Suzhou Hengrui Medical Equipment Business Overview Table 65. Suzhou Hengrui Medical Equipment Drug-Loadable Embolic Microspheres Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Suzhou Hengrui Medical Equipment Drug-Loadable Embolic Microspheres Product Portfolio Table 67. Suzhou Hengrui Medical Equipment Recent Development Table 68. Cardiolink Science Company Information Table 69. Cardiolink Science Business Overview Table 70. Cardiolink Science Drug-Loadable Embolic Microspheres Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Cardiolink Science Drug-Loadable Embolic Microspheres Product Portfolio Table 72. Cardiolink Science Recent Development Table 73. Varian Company Information Table 74. Varian Business Overview Table 75. Varian Drug-Loadable Embolic Microspheres Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Varian Drug-Loadable Embolic Microspheres Product Portfolio Table 77. Varian Recent Development Table 78. Terumo Company Information Table 79. Terumo Business Overview Table 80. Terumo Drug-Loadable Embolic Microspheres Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Terumo Drug-Loadable Embolic Microspheres Product Portfolio Table 82. Terumo Recent Development Table 83. Sirtex Medical Company Information Table 84. Sirtex Medical Business Overview Table 85. Sirtex Medical Drug-Loadable Embolic Microspheres Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Sirtex Medical Drug-Loadable Embolic Microspheres Product Portfolio Table 87. Sirtex Medical Recent Development Table 88. Merit Medical Company Information Table 89. Merit Medical Business Overview Table 90. Merit Medical Drug-Loadable Embolic Microspheres Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Merit Medical Drug-Loadable Embolic Microspheres Product Portfolio Table 92. Merit Medical Recent Development Table 93. Boston Scientific Company Information Table 94. Boston Scientific Business Overview Table 95. Boston Scientific Drug-Loadable Embolic Microspheres Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Boston Scientific Drug-Loadable Embolic Microspheres Product Portfolio Table 97. Boston Scientific Recent Development Table 98. ABK Biomedical Company Information Table 99. ABK Biomedical Business Overview Table 100. ABK Biomedical Drug-Loadable Embolic Microspheres Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. ABK Biomedical Drug-Loadable Embolic Microspheres Product Portfolio Table 102. ABK Biomedical Recent Development Table 103. Key Raw Materials Table 104. Raw Materials Key Suppliers Table 105. Drug-Loadable Embolic Microspheres Distributors List Table 106. Drug-Loadable Embolic Microspheres Customers List Table 107. Research Programs/Design for This Report Table 108. Authors List of This Report Table 109. Secondary Sources Table 110. Primary Sources List of Figures Figure 1. Drug-Loadable Embolic Microspheres Product Image Figure 2. Global Drug-Loadable Embolic Microspheres Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Drug-Loadable Embolic Microspheres Market Size (2021-2032) & (US$ Million) Figure 4. Global Drug-Loadable Embolic Microspheres Sales (2021-2032) & (K Units) Figure 5. Global Drug-Loadable Embolic Microspheres Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Drug-Loadable Embolic Microspheres Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Radioactive Microspheres Image Figure 9. Drug-eluting Microspheres Image Figure 10. Global Drug-Loadable Embolic Microspheres Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Drug-Loadable Embolic Microspheres Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Drug-Loadable Embolic Microspheres Sales Market Share by Type (2021-2032) Figure 13. Global Drug-Loadable Embolic Microspheres Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Drug-Loadable Embolic Microspheres Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Drug-Loadable Embolic Microspheres Revenue Market Share by Type (2021-2032) Figure 16. Primary Liver Cancer Image Figure 17. Colorectal Cancer Liver Metastasis Image Figure 18. Others Image Figure 19. Global Drug-Loadable Embolic Microspheres Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Drug-Loadable Embolic Microspheres Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Drug-Loadable Embolic Microspheres Sales Market Share by Application (2021-2032) Figure 22. Global Drug-Loadable Embolic Microspheres Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Drug-Loadable Embolic Microspheres Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Drug-Loadable Embolic Microspheres Revenue Market Share by Application (2021-2032) Figure 25. North America Drug-Loadable Embolic Microspheres Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Drug-Loadable Embolic Microspheres Sales Market Share by Country (2021-2032) Figure 27. U.S. Drug-Loadable Embolic Microspheres Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Drug-Loadable Embolic Microspheres Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Drug-Loadable Embolic Microspheres Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Drug-Loadable Embolic Microspheres Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Drug-Loadable Embolic Microspheres Sales Market Share by Country (2021-2032) Figure 32. Germany Drug-Loadable Embolic Microspheres Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Drug-Loadable Embolic Microspheres Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Drug-Loadable Embolic Microspheres Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Drug-Loadable Embolic Microspheres Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Drug-Loadable Embolic Microspheres Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Drug-Loadable Embolic Microspheres Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Drug-Loadable Embolic Microspheres Sales Market Share by Country (2021-2032) Figure 39. China Drug-Loadable Embolic Microspheres Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Drug-Loadable Embolic Microspheres Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Drug-Loadable Embolic Microspheres Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Drug-Loadable Embolic Microspheres Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Drug-Loadable Embolic Microspheres Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Drug-Loadable Embolic Microspheres Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Drug-Loadable Embolic Microspheres Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Drug-Loadable Embolic Microspheres Sales Market Share by Country (2021-2032) Figure 47. Brazil Drug-Loadable Embolic Microspheres Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Drug-Loadable Embolic Microspheres Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Drug-Loadable Embolic Microspheres Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Drug-Loadable Embolic Microspheres Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Drug-Loadable Embolic Microspheres Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Drug-Loadable Embolic Microspheres Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Drug-Loadable Embolic Microspheres Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Drug-Loadable Embolic Microspheres Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Drug-Loadable Embolic Microspheres Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Drug-Loadable Embolic Microspheres Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Drug-Loadable Embolic Microspheres Revenue (2021-2032) & (US$ Million) Figure 58. North America Drug-Loadable Embolic Microspheres Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Drug-Loadable Embolic Microspheres Revenue (2021-2032) & (US$ Million) Figure 60. Europe Drug-Loadable Embolic Microspheres Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Drug-Loadable Embolic Microspheres Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Drug-Loadable Embolic Microspheres Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Drug-Loadable Embolic Microspheres Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Drug-Loadable Embolic Microspheres Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Drug-Loadable Embolic Microspheres Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Drug-Loadable Embolic Microspheres Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Radioactive Microspheres
  • Drug-eluting Microspheres
Applications
  • Primary Liver Cancer
  • Colorectal Cancer Liver Metastasis
  • Others
Companies covered
  • Suzhou Hengrui Medical Equipment
  • Cardiolink Science
  • Varian
  • Terumo
  • Sirtex Medical
  • Merit Medical
  • Boston Scientific
  • ABK Biomedical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Drug-Loadable Embolic Microspheres Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Drug-Loadable Embolic Microspheres Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Drug-Loadable Embolic Microspheres Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Drug-Loadable Embolic Microspheres Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Drug-Loadable Embolic Microspheres Market Dynamics
  1. 2.1 Drug-Loadable Embolic Microspheres Industry Trends
  2. 2.2 Drug-Loadable Embolic Microspheres Industry Drivers
  3. 2.3 Drug-Loadable Embolic Microspheres Industry Opportunities and Challenges
  4. 2.4 Drug-Loadable Embolic Microspheres Industry Restraints
3 Drug-Loadable Embolic Microspheres Market by Manufacturers
  1. 3.1 Global Drug-Loadable Embolic Microspheres Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Drug-Loadable Embolic Microspheres Sales by Manufacturers (2021-2026)
  3. 3.3 Global Drug-Loadable Embolic Microspheres Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Drug-Loadable Embolic Microspheres Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Drug-Loadable Embolic Microspheres Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Drug-Loadable Embolic Microspheres Manufacturers, Product Type & Application
  7. 3.7 Global Drug-Loadable Embolic Microspheres Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Drug-Loadable Embolic Microspheres Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Drug-Loadable Embolic Microspheres Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Drug-Loadable Embolic Microspheres Tier 1, Tier 2, and Tier 3
4 Drug-Loadable Embolic Microspheres Market by Type
  1. 4.1 Drug-Loadable Embolic Microspheres Type Introduction
  2. 4.1.1 Radioactive Microspheres
  3. 4.1.2 Drug-eluting Microspheres
  4. 4.2 Global Drug-Loadable Embolic Microspheres Sales by Type
  5. 4.2.1 Global Drug-Loadable Embolic Microspheres Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Drug-Loadable Embolic Microspheres Sales by Type (2021-2032)
  7. 4.2.3 Global Drug-Loadable Embolic Microspheres Sales Market Share by Type (2021-2032)
  8. 4.3 Global Drug-Loadable Embolic Microspheres Revenue by Type
  9. 4.3.1 Global Drug-Loadable Embolic Microspheres Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Drug-Loadable Embolic Microspheres Revenue by Type (2021-2032)
  11. 4.3.3 Global Drug-Loadable Embolic Microspheres Revenue Market Share by Type (2021-2032)
5 Drug-Loadable Embolic Microspheres Market by Application
  1. 5.1 Drug-Loadable Embolic Microspheres Application Introduction
  2. 5.1.1 Primary Liver Cancer
  3. 5.1.2 Colorectal Cancer Liver Metastasis
  4. 5.1.3 Others
  5. 5.2 Global Drug-Loadable Embolic Microspheres Sales by Application
  6. 5.2.1 Global Drug-Loadable Embolic Microspheres Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Drug-Loadable Embolic Microspheres Sales by Application (2021-2032)
  8. 5.2.3 Global Drug-Loadable Embolic Microspheres Sales Market Share by Application (2021-2032)
  9. 5.3 Global Drug-Loadable Embolic Microspheres Revenue by Application
  10. 5.3.1 Global Drug-Loadable Embolic Microspheres Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Drug-Loadable Embolic Microspheres Revenue by Application (2021-2032)
  12. 5.3.3 Global Drug-Loadable Embolic Microspheres Revenue Market Share by Application (2021-2032)
6 Global Drug-Loadable Embolic Microspheres Sales by Region
  1. 6.1 Global Drug-Loadable Embolic Microspheres Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Drug-Loadable Embolic Microspheres Sales by Region (2021-2032)
  3. 6.2.1 Global Drug-Loadable Embolic Microspheres Sales by Region (2021-2026)
  4. 6.2.2 Global Drug-Loadable Embolic Microspheres Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Drug-Loadable Embolic Microspheres Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Drug-Loadable Embolic Microspheres Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Drug-Loadable Embolic Microspheres Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Drug-Loadable Embolic Microspheres Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Drug-Loadable Embolic Microspheres Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Drug-Loadable Embolic Microspheres Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Drug-Loadable Embolic Microspheres Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Drug-Loadable Embolic Microspheres Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Drug-Loadable Embolic Microspheres Revenue by Region
  1. 7.1 Global Drug-Loadable Embolic Microspheres Revenue by Region
  2. 7.1.1 Global Drug-Loadable Embolic Microspheres Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Drug-Loadable Embolic Microspheres Revenue by Region (2021-2026)
  4. 7.1.3 Global Drug-Loadable Embolic Microspheres Revenue by Region (2027-2032)
  5. 7.1.4 Global Drug-Loadable Embolic Microspheres Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Drug-Loadable Embolic Microspheres Revenue (2021-2032)
  8. 7.2.2 North America Drug-Loadable Embolic Microspheres Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Drug-Loadable Embolic Microspheres Revenue (2021-2032)
  11. 7.3.2 Europe Drug-Loadable Embolic Microspheres Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Drug-Loadable Embolic Microspheres Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Drug-Loadable Embolic Microspheres Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Drug-Loadable Embolic Microspheres Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Drug-Loadable Embolic Microspheres Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Suzhou Hengrui Medical Equipment
  2. 8.1.1 Suzhou Hengrui Medical Equipment Company Information
  3. 8.1.2 Suzhou Hengrui Medical Equipment Business Overview
  4. 8.1.3 Suzhou Hengrui Medical Equipment Drug-Loadable Embolic Microspheres Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Suzhou Hengrui Medical Equipment Drug-Loadable Embolic Microspheres Product Portfolio
  6. 8.1.5 Suzhou Hengrui Medical Equipment Recent Developments
  7. 8.2 Cardiolink Science
  8. 8.2.1 Cardiolink Science Company Information
  9. 8.2.2 Cardiolink Science Business Overview
  10. 8.2.3 Cardiolink Science Drug-Loadable Embolic Microspheres Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Cardiolink Science Drug-Loadable Embolic Microspheres Product Portfolio
  12. 8.2.5 Cardiolink Science Recent Developments
  13. 8.3 Varian
  14. 8.3.1 Varian Company Information
  15. 8.3.2 Varian Business Overview
  16. 8.3.3 Varian Drug-Loadable Embolic Microspheres Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Varian Drug-Loadable Embolic Microspheres Product Portfolio
  18. 8.3.5 Varian Recent Developments
  19. 8.4 Terumo
  20. 8.4.1 Terumo Company Information
  21. 8.4.2 Terumo Business Overview
  22. 8.4.3 Terumo Drug-Loadable Embolic Microspheres Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Terumo Drug-Loadable Embolic Microspheres Product Portfolio
  24. 8.4.5 Terumo Recent Developments
  25. 8.5 Sirtex Medical
  26. 8.5.1 Sirtex Medical Company Information
  27. 8.5.2 Sirtex Medical Business Overview
  28. 8.5.3 Sirtex Medical Drug-Loadable Embolic Microspheres Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Sirtex Medical Drug-Loadable Embolic Microspheres Product Portfolio
  30. 8.5.5 Sirtex Medical Recent Developments
  31. 8.6 Merit Medical
  32. 8.6.1 Merit Medical Company Information
  33. 8.6.2 Merit Medical Business Overview
  34. 8.6.3 Merit Medical Drug-Loadable Embolic Microspheres Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Merit Medical Drug-Loadable Embolic Microspheres Product Portfolio
  36. 8.6.5 Merit Medical Recent Developments
  37. 8.7 Boston Scientific
  38. 8.7.1 Boston Scientific Company Information
  39. 8.7.2 Boston Scientific Business Overview
  40. 8.7.3 Boston Scientific Drug-Loadable Embolic Microspheres Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Boston Scientific Drug-Loadable Embolic Microspheres Product Portfolio
  42. 8.7.5 Boston Scientific Recent Developments
  43. 8.8 ABK Biomedical
  44. 8.8.1 ABK Biomedical Company Information
  45. 8.8.2 ABK Biomedical Business Overview
  46. 8.8.3 ABK Biomedical Drug-Loadable Embolic Microspheres Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 ABK Biomedical Drug-Loadable Embolic Microspheres Product Portfolio
  48. 8.8.5 ABK Biomedical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Drug-Loadable Embolic Microspheres Value Chain Analysis
  2. 9.1.1 Drug-Loadable Embolic Microspheres Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Drug-Loadable Embolic Microspheres Production Mode & Process
  6. 9.2 Drug-Loadable Embolic Microspheres Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Drug-Loadable Embolic Microspheres Distributors
  9. 9.2.3 Drug-Loadable Embolic Microspheres Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst